It is well-documented that lycopene inhibits NF-kB binding activity and target gene expression, especially of NF-kB and MMP-9-associated gene targets, which prohibits the cell invasion of hepatoma in humans. The gene discussed is NFKB1; the disease is hepatocellular carcinoma.